SFG
PFE icon

Snider Financial Group’s Pfizer PFE Stock Holding History

Snider Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,230
Closed -$261K – 116
2025
Q3 		$261K Sell
10,230
-1,940
-16% -$47.9K 0.07% 101
2025
Q2 		$295K Buy
12,170
+745
+7% +$17.4K 0.09% 96
2025
Q1 		$290K Sell
11,425
-2,220
-16% -$58.1K 0.09% 96
2024
Q4 		$362K Buy
+13,645
New +$370K 0.11% 84

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Snider Financial Group's PFE Position: Q4 2025 in Review

Snider Financial Group sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,230 shares — an estimated $261K sold.

Snider Financial Group first reported a position in PFE in Q4 2024 and held it in 4 quarters. The position peaked at $362K in Q4 2024. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Snider Financial Group reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Snider Financial Group sold 10,230 Pfizer shares in Q4 2025, an estimated $261K.
  • Snider Financial Group first reported a position in Pfizer in Q4 2024 and held it in 4 quarters.
  • Snider Financial Group's Pfizer position peaked at $362K in Q4 2024.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Snider Financial Group's 13F filing for Q4 2025, filed 21 Jan 2026.